City of Hope

www.cityofhope.org

 

City of Hope
M

Practical Perspectives on Recent CAR-T FDA Approvals in Myeloma

By City of Hope FEATURING Murali Janakiram
By City of Hope FEATURING Murali Janakiram
189 views
April 26, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
Myeloma
11:43
City of Hope

Practical Perspectives on Recent CAR-T FDA Approvals in Myeloma

Feat. M. Janakiram
20:46
ASH 2022 Conference Coverage

ASH 2022 Understanding and Monitoring Resistance to Anti-CD38 and -B…

Feat. F. Pichiorri
07:29
City of Hope

ASCO 2021 Updated Phase 1 Results of Teclistamab, a B-Cell Maturatio…

Feat. A. Krishnan
18:44
City of Hope

The Promise of Immunotherapy and Newer Agents in Multiple Myeloma

Feat. A. Krishnan
17:58
City of Hope

Should Everyone Receive Monoclonal Antibodies at First Myeloma Relap…

Feat. J. Mikhael